JohnJacobOrloffMD

Endocrinology • Chester, NJ

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Orloff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Orloff's full profile

Already have an account?

Office
2 Fieldcrest Rd
Chester, NJ 07930
Phone+1 862-778-3586

Education & Training

Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
UPMC Medical EducationResidency, Internal Medicine, 1984 - 1986
University of Vermont College of MedicineClass of 1983

Certifications & Licensure

NJ State Medical License 1998 - 2017

Publications & Presentations

PubMed

12 citations
Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy.
Weiyi Yang, Kristijan H. Kahler, Thomas Fellers, John Orloff, Joanne Chang
Journal of Medical Economics. 2011-05-18
8 citations
Innovative approaches to clinical development and trial design
John Orloff, Donald R. Stanski
Annali Dell'istituto Superiore Di Sanita. 2011-01-01
8 citations
Compliance, persistence, healthcare resource use, and treatment costs associated with aliskiren plus ARB versus ACE inhibitor plus ARB combination therapy: in US patie...
Joanne Chang, Weiyi Yang, Kristijan H. Kahler, Thomas Fellers, John Orloff
American Journal of Cardiovascular Drugs. 2011-01-01

Press Mentions

Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and Tolerability of CAEL-101 in AL Amyloidosis at the European Hematology Association Congress 2021June 11th, 2021
Alexion Announces FDA Approval of ULTOMIRIS® (Ravulizumab-Cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)June 7th, 2021
FDA Approves New Ultomiris Formulation That Shortens Infusion TimeOctober 14th, 2020
Join now to see all